BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22345985)

  • 1. A six-nucleotide deletion polymorphism in the casp8 promoter is associated with reduced risk of esophageal and gastric cancers in Kashmir valley.
    Malik MA; Zargar SA; Mittal B
    Indian J Hum Genet; 2011 Sep; 17(3):152-6. PubMed ID: 22345985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.
    Du H; Song GX; Fang MZ; Shu YQ; Zhao X; Zhu LJ
    J Biomed Res; 2019 Jun; 33(3):173-180. PubMed ID: 30057371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.
    Wang M; Zhang Z; Tian Y; Shao J; Zhang Z
    Clin Cancer Res; 2009 Apr; 15(7):2567-72. PubMed ID: 19276244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men.
    Fu G; Tang J; Wang M; Qin C; Yan F; Ding Q; Yin C; Wang X; Zhang Z
    J Biomed Res; 2011 Mar; 25(2):128-34. PubMed ID: 23554680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
    Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
    Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
    Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
    Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
    Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
    Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
    Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
    Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
    Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.
    Zhu J; Qin C; Wang M; Yan F; Ju X; Meng X; Ding Q; Li P; Yang J; Cao Q; Zhang Z; Yin C
    Mol Carcinog; 2010 Sep; 49(9):810-7. PubMed ID: 20572163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous Ins/Del genotype of the CASP8 rs3834129 polymorphism significantly decreases the risk of coal workers' pneumoconiosis in a Chinese Han population: a case-control study.
    Hou ZF; Wang H; Ji SQ; Kang DM; Zhao H; Guo Y; Ma JF; Wang JZ; Ma X; Gao Y
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7726-7733. PubMed ID: 34982434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.
    Chen D; Ma T; Liu XW; Liu Z
    Exp Ther Med; 2012 Oct; 4(4):762-770. PubMed ID: 23170140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
    Ji GH; Li M; Cui Y; Wang JF
    Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cai J; Ye Q; Luo S; Zhuang Z; He K; Zhuo ZJ; Wan X; Cheng J
    Oncotarget; 2017 Aug; 8(34):56780-56790. PubMed ID: 28915630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.